PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Circ Arrhythm Electrophysiol. Author manuscript; available in PMC 2010 August 1.
Published in final edited form as:
PMCID: PMC2772163
NIHMSID: NIHMS126575

Clinical correlates and heritability of QT interval duration in African Americans: the Jackson Heart Study

Abstract

Background

Electrocardiographic QT interval prolongation is a risk factor for sudden cardiac death (SCD) and drug-induced arrhythmia. The clinical correlates and heritability of QT interval duration in African Americans have not been well studied despite their higher risk for SCD compared to non-Hispanic whites. We sought to investigate potential correlates of the QT interval and estimate its heritability in the Jackson Heart Study (JHS).

Methods and Results

The JHS comprises a sample of African Americans residing in Jackson, Mississippi, of whom 5302 individuals with data at the baseline examination were available for study. JHS participants on QT-altering medications, with bundle branch block, paced rhythm, atrial fibrillation/flutter or other arrhythmias were excluded resulting in a sample of 4660 individuals eligible for analyses. The relation between QT and potential covariates was tested using multivariable stepwise linear regression. Heritability was estimated using SOLAR in a subset of 1297 JHS participants in 292 families; the remaining sample included unrelated individuals. In stepwise multivariable linear regression analysis, covariates significantly associated with QT interval duration included RR interval, female sex, QRS duration, age, lower potassium, hypertension, body mass index, coronary heart disease, diuretic use, and Sokolow-Lyon voltage (p ≤ 0.01 for all). The heritability of QT interval duration in age-, sex- and RR-interval-adjusted and fully-adjusted models was 0.41 (SE 0.07) and 0.40 (SE 0.07, p<10−11 for both), respectively.

Conclusions

There is substantial heritability of adjusted QT interval in African Americans supporting the need for further investigation to identify its genetic determinants.

Keywords: QT interval, Genetics, Heritability, Jackson Heart Study

Sudden cardiac death (SCD) claims 300,000 lives annually in the United States.1 African Americans have higher rates of SCD than European Americans but the causes of the difference in event rates are unknown.25 Risk factors for SCD in the general population include coronary artery disease, hypertension, tobacco use, electrocardiographic QT interval prolongation, left ventricular hypertrophy, diabetes, body mass index and family history.69 The increased risk of SCD in African Americans could result from environmental differences, including diet or smoking, from disparities in access to health care or from aggregation of multiple risk factors with strong biologic underpinnings, such as increased rates of hypertension and left ventricular hypertrophy.10

Family history is a consistent risk factor for SCD.6,1113 Whether heritable factors contribute to the higher risk of SCD in African Americans compared to European Americans is unknown. A common missense variant in the SCN5A sodium channel (S1102Y) found exclusively in individuals of African ancestry has been found to increase risk of ventricular arrhythmias and sudden cardiac death.14,15 A common missense variant in the beta-2 adrenergic receptor (Gln27Glu) that is more frequent in African Americans has been found to increase risk of SCD in European Americans, and had borderline significance in a small African American sample.16 While an aggregation of many such genetic variants could contribute incrementally to differential SCD risk, existing studies of SCD in African and European Americans lack statistical power to define the full spectrum of common and rare variants that contribute to SCD risk.

The electrocardiographic QT interval is a reflection of myocardial depolarization and repolarization time. QT interval prolongation17,18 or shortening19 is associated with increased risk of SCD in community-based samples as well as in familial congenital syndromes of long and short QT duration and ventricular arrhythmias.2022 Moreover, QT interval prolongation and ventricular arrhythmia upon exposure to cardiac and non-cardiac medications is a life-threatening side effect and a major barrier to drug development.23 The widespread availability of QT interval measurements in multiple cohorts makes it an attractive intermediate SCD trait and enables well-powered studies of the determinants of myocardial repolarization in the general population.

It has been shown that RR-interval-, sex- and age- adjusted QT interval duration in community-based samples of European ancestry is heritable.24 Heritability, quantifying the tendency of related individuals to have more similar trait values than unrelated individuals, estimates the proportion of variation in a trait that is explainable by additive genetic factors. Heritability in the Framingham Heart Study, a sample of European ancestry, has been estimated at 0.35, indicating that 35% of variation in adjusted QT interval duration was attributable to additive genetic factors.24 While a large-scale study by Dekker et al. has established several clinical correlates of QT interval duration on univariable analysis in African American community-based samples,18 limited data on the independent correlates of QT interval duration on multivariable analysis or its heritability in African Americans are currently available.

We sought to define the clinical correlates of QT interval duration in 4660 Jackson Heart Study (JHS) participants and to determine the heritability of multivariable-adjusted QT interval duration in the family-based subset of 1500 JHS participants. Demonstration that a significant proportion of multivariable-adjusted QT interval variation in African Americans is attributable to genetic factors would support efforts to identify those genetic factors which could then be examined for association with SCD risk or drug-induced arrhythmias in the general population.

Methods

Study Sample

The Jackson Heart Study (JHS) cohort includes individuals recruited from the greater Jackson, Mississippi area25 some of whom were originally participants in the Atherosclerosis Risk in Communities Study (ARIC).26 Men and women aged 35–84 years were included as well as family members aged 21 or older who agreed to participate in the family study component27 with a final study cohort of 5302 participants aged 21–95. DNA samples were extracted from all JHS participants who consented to genetic studies. The pedigree data stored in the software package Progeny 2000 (www.progenygenetics.com) were checked for inconsistencies including same-sex married couples, pedigree loops, incompatible age, and ID problems. A total of 1500 individuals in 292 families had microsatellites genotyped by the Mammalian Genotyping Service (research.marshfieldclinic.org/genetics/home/index.asp). Using microsatellite markers, pedigree relationships underwent modification to resolve Mendelian and single-marker inconsistencies.27

Of 5302 total JHS participants in the unrelated (n = 3802) and family (n = 1500) components, those without informed consent (0.2%) or electrocardiographic data (0.3%), those on digoxin (1.5%) or a QT-prolonging medication (4.8%, listed in Supplemental Table 1), and those with left or right bundle branch block (2.2%), atrial fibrillation or atrial flutter (0.4%), other arrhythmias (0.3%), or a pacemaker (0.2%) were excluded, resulting in the final sample of 4660 individuals who were eligible for analysis (n = 3363 in the unrelated sample and n = 1297 in the family sample). The total sample of 4660 individuals contributed to association analysis of clinical covariates and the related subsample of 1297 individuals in 292 families contributed to the heritability analyses.

Clinical characteristic ascertainment

The baseline examination consisted of a home interview, self-administered questionnaires, and a clinic visit. Medications taken in the prior 2 weeks were brought to clinic and transcribed verbatim with subsequent coding by a pharmacist using the Medispan dictionary (www.medispan.com/index.aspx) with classification according to the Anatomical Therapeutic Chemical Classification System (www.who.int/classifications/atcddd/en/). QT-prolonging medications were annotated using the lists of medications maintained by qtdrugs.org (www.arizonacert.org/medical-pros/drug-lists/drug-lists.htm, accessed November, 2006). Digoxin use, which shortens QT interval duration, was also annotated. After an overnight fast, anthropometric and seated blood pressure measurements were obtained and venipuncture was performed. Blood pressure was measured after a 5 minute rest by trained staff in the right arm of seated participants, whose back and arm were supported, using an appropriately sized cuff and a Hawksley random-zero sphygmomanometer. The average of 2 measures taken one minute apart was recorded. Hypertension was defined as a measured blood pressure ≥140/90 mmHg or use of antihypertensive medication. Presence of coronary heart disease (CHD) was determined by self-reported history, physician-diagnosed- or ECG-determined myocardial infarction, or self-reported angioplasty. Presence of diabetes was established by self-report or by a measured fasting glucose of ≥126 mg/dl, or use of insulin and/or oral hypoglycemic agents . Blood samples from the fasting venipuncture were analyzed for several analytes including potassium, glucose, total cholesterol, high-density lipoprotein cholesterol, and triglycerides standardized according to the Centers for Disease Control and Prevention as previously described.25 Low-density lipoprotein cholesterol was calculated according to the Friedewald equation. Higher alcohol use was defined as consumption of >14 drinks per week for men and >7 drinks per week for women. Four physical activity index scores, for Active Living, Work, Sport, and Home and Family Life, were calculated based on the physical activity cohort survey administered during the home induction interview. For each index, the values ranged from one (low) to five (high). The four individual index values were summed to obtain the total physical activity index (ranging from 4 to 20).28

ECG measurements

The clinical examination included supine 12-lead digital electrocardiography using a Marquette MAC/PC digital electrocardiograph to record, store, and transmit ECG data via phone modem to the Electrocardiographic Reading Center (ECGRC) at the University of Minnesota.25 The ECGRC used the Minnesota Code Modular ECG Analysis System (MC-MEANS) computer program for all baseline examination ECGs, which has performed well when compared to other computer algorithms and manual reads by cardiologists.29,30 MC-MEANS generates a representative averaged beat and determines onsets and offsets of P, QRS, and T waves simultaneously over all leads. The PR interval is the time from onset of the P wave to onset of the QRS complex. The QRS duration is the time from the onset of the Q wave to the offset of the S wave. The QT interval is the time from the onset of the Q wave to the offset of the T wave. These data are the basis for all continuous measurements and are coded using a morphology decision logic algorithm. These preliminary codes were then subjected to hierarchical exclusion rules from the Minnesota Code. Sokolow-Lyon voltage was calculated as the sum of the S-wave amplitude in lead V1 and the greater of the R-wave amplitudes in V5 and V6.

Statistical methods

Participant baseline characteristics such as age, body mass index (BMI), systolic and diastolic blood pressure, use of antihypertensive medication, use of diuretics, hypertension, fasting glucose, fasting lipid profile (total, LDL, and HDL cholesterol and triglyceride level), serum potassium level, type 2 diabetes status, CHD status, physical activity index and electrocardiographic QT interval, RR interval, PR interval (lead II) and QRS duration were studied. The characteristics were summarized descriptively, in sex-pooled and sex-specific analyses, using means and standard deviations for continuous parameters and using percentages for categorical parameters. Sex-specific means, standard deviations (SD), interquartile ranges (IQR) and ranges for QT interval adjusted for heart rate using Bazett's correction (QTc) were computed.31

Linear regression analyses were performed to identify baseline demographic and clinical characteristics associated with QT interval duration. Initially, linear regression models that included QT interval duration as the dependent variable and a clinical characteristic along with three concomitant variables (age, sex, and RR interval) as independent factors were utilized to explore the relationship of each clinical characteristic individually with QT interval duration. Factors that were statistically significant (p<0.05) in these models were selected for stepwise model building. A separate analysis of systolic and diastolic blood pressure, hypertension status, and use of anti-hypertensive medications, all of which individually were significant in the age-, sex-, and RR-adjusted analysis, was conducted using a linear regression model with stepwise selection, after forcing in age, sex, and RR interval. Based on the model R-square statistic and Mallows' Cp statistic, only hypertension status was chosen for inclusion in the final model as the predictor of QT interval with the greatest explanatory power among blood pressure-related factors. All factors identified for the final model selection were then tested using a multivariable linear regression model with stepwise backward elimination and retention of variables with p<0.05 in the final model.

Finally, two linear regression models were examined to obtain heritability estimates for the sample. The first model included only age, sex, and RR interval (model 1), while age, sex, RR interval and all additional factors with p<0.05 in the multivariable model were included in the second model (model 2). Heritability analyses in either model were restricted to the 1297 participants in 292 families with complete information for all characteristics in model 2 to allow comparison. The values of the standardized adjusted residuals, Winsorized at 3 standard deviations, obtained from the two models, were analyzed using variance components methods implemented in SOLAR, which parses genetic and nongenetic components of variation in a trait, to estimate heritability.32

Results

Baseline characteristics after exclusion of individuals on QT-altering medications, or with left or right bundle branch block, arrhythmia or paced rhythm are presented in Table 1. The sample population was obese on average with mean BMI 31.7 kg/m2 and had a high prevalence of hypertension (60%), diabetes (17%), and CHD (5.6%). The mean QT interval was longer in women (416.5 msec, SD 30.6) compared to men (407.4 msec, SD 30.0, p for difference = ) as expected. The mean RR interval was 981 msec (SD 159) in men and 942 (148) in women. We compared the heart rate-adjusted QT interval in the 4660 men and women not on any QT-altering medications to that in the 223 individuals taking QT-prolonging medications and in the 45 individuals taking digoxin, known to shorten QT interval duration. Men who were not taking any QT-altering medication had a QTc of 413.1 msec (SD 25.3), compared to 422.7 msec (SD 25.3, p for difference = 0.008) for men on QT-prolonging medication and 412.3 msec for men on digoxin (SD 31.5, p for comparison to group on no QT-altering medication = 0.90). Women not taking any QT-altering medication had a QTc of 430.8 msec (SD 24.0), compared to 440.9 msec (SD 25.4, p < 0.0001) for women on QT-prolonging medication and 406.9 msec (SD 33.8, p < 0.0001) for women on digoxin.

Table 1
Baseline Characteristics of the Jackson Heart Study Participants Free of Exclusions

In the initial linear regression analyses (adjusting only for age, sex, and RR interval), the following factors were significant predictors of QT interval duration (p<0.05) when added individually: age, sex, RR interval, QRS duration, PR interval, hypertension, systolic blood pressure, diastolic blood pressure, antihypertensive medication, diuretic use, Sokolow-Lyon voltage, body mass index, current smoking, physical activity index, prevalent coronary heart disease, and serum potassium (Table 2). In a stepwise linear regression analysis of hypertension status, systolic and diastolic blood pressure and anti-hypertensive use, hypertension status entered into the model first and explained the greatest proportion of variation in QT interval duration compared to the other three variables and was thus used in subsequent analyses for ease of interpretation (data not shown). In the backward stepwise multivariable linear regression analysis, the following factors were independently positively associated (p<0.05) with increase in QT interval duration: RR interval, female sex, QRS duration, age, hypertension, BMI, CHD status, diuretic use and Sokolow-Lyon voltage (Table 3). Serum potassium was negatively associated with QT interval duration (p<0.0001). The majority of variation in QT interval duration was explained by RR interval (47%), female sex (5%), QRS duration (3%) and age (2%). All other factors explained less than 1% of variation in QT interval duration. The correlation of residuals from the age-, sex- and RR-interval-adjusted model (54% variation explained) and those from the fully-adjusted model (58% variation explained) was 0.99.

Table 2
Baseline Characteristics Associated with QT Duration
Table 3
Independent effect of Clinical Covariates on QT Interval Duration in JHS Participants in Stepwise Multivariable Linear Regression

The estimated heritability of RR interval-, sex- and age-adjusted QT interval residuals was 0.40 (SE 0.07, p<10−11) and for residuals from the fully-adjusted model shown in Table 3 was 0.41 (SE 0.07, p<10−11, Table 4).

Table 4
Adjusted QT interval duration and heritability

Discussion

In this study, several independent clinical correlates of QT interval duration in a large, African American community-based sample were identified and were consistent with several correlates previously reported in the literature. It was demonstrated for the first time that adjusted QT interval duration was a heritable trait with a substantial proportion of variation explained by additive genetic factors in African Americans.

QT interval duration was found to be positively associated with RR interval, female sex, QRS duration, age, hypertension, body mass index, coronary heart disease, use of diuretics, and Sokolow-Lyon voltage and negatively associated with serum potassium. These observations were consistent with findings reported by Dekker et al. in whites and blacks from the Atherosclerosis Risk in Communities study that increasing QTc quintiles showed significant trends for increasing age, hypertension prevalence, and body mass index and decreasing serum potassium on adjustment for age, sex and race when these factors were considered individually.18 No significant associations of triglycerides, total cholesterol, HDL cholesterol, or diabetes with QT interval was found in JHS regression models adjusted for age, sex and RR-interval but were by Dekker et al. This could reflect chance differences between JHS and ARIC cohorts or reduced power in the JHS sample because of the smaller total sample size. The two studies included only 1601 individuals in common who were examined between 1987 and 1989 in ARIC and between 2000 and 2004 in the JHS. Alternatively, some of the associations in the analyses by Dekker et al. could have been driven by effects in the white component of the ARIC cohort in the race-adjusted analyses in the combined sample.

In the Jackson Heart Study, there was a strong association of increasing QT interval with diuretic use and with decreasing serum potassium. It would be expected that diuretic use might be associated with QT interval duration in a community-based sample because of its relationship with total body potassium loss. The observation that serum potassium and diuretic use were independently significant in the same model could reflect the known impact of diuretic-induced hypomagnesemia on QT interval duration33 the incomplete correlation between one-time serum potassium measures and total body potassium stores.

Prospective studies have shown that QT interval duration is predictive of incident coronary heart disease, even after adjustment for known coronary heart disease risk factors in individuals of African or of European ancestry.18,34,35 In the JHS, the QT interval was shown to be positively associated with prevalent coronary heart disease, which could be due to an intrinsic predictive nature of adjusted QT interval on incident CHD or some reflection of acquired derangements of depolarization or repolarization that follow the development of CHD or aggregation of its risk factors.

In addition, a positive association was found between QT interval duration and increasing Sokolow-Lyon voltage, an electrocardiographic correlate of left ventricular mass. Left ventricular hypertrophy, measured by electrocardiography or echocardiography, has been associated with QRS lengthening (presumably from myocardial hypertrophy and fibrosis) and QT prolongation in hypertensive subjects.36,37 It is important to note that the large sample size of over 4000 individuals means that even clinically insignificant effects on QT interval duration can reach strong statistical significance. The partial R2, reflecting the fraction of variation explained by a clinical factor, was 0.47 for RR interval, 0.05 for female sex, 0.03 for QRS and 0.02 for age. All other covariates explain less than one percent of variation in QT interval and thus contribute little to the regression model; these could easily be dropped from analyses without altering results substantially. Because the QRS duration is a subcomponent of the QT interval, it may not be appropriate to adjust for it and most studies do not.

There is evidence that a substantial fraction of QT interval variability after adjustment for known covariates is explained by additive heritable factors in European-derived samples. The finding that 40–41% of variation in adjusted QT interval in African Americans is attributable to genetic factors is consistent with previous reports in individuals of European ancestry in the Framingham Heart Study (35%) and in the Family Heart Study (34%).24,38 It is important to establish that a heritable basis for a complex trait such as QT interval duration exists before embarking on genetic studies. Because of the known influences of diurnal variability, effects of adrenergic stimulation and measurement error on QT interval measures, it is certainly possible that an even greater proportion of the biologically meaningful component of QT interval variation is explained by genetic factors.

Strengths of the current report include the large sample size, the broad range of precisely measured covariates, the simultaneous adjustment for multiple risk factors and the availability of a family component to allow estimation of heritability of QT interval in African Americans. Limitations to the study must be acknowledged. The power to detect any true underlying association of a factor with QT interval is a function of both the strength of effect and the prevalence of the factor. Thus, the failure to find association of higher alcohol use or diabetes could be due to limited power. Lastly, QT interval measurements are limited by ambiguity of the T-wave offset and different computer algorithms can define this differently. However, the same well-validated computer algorithm was applied to the entire sample and any imprecision in T-wave offset would be expected to add noise to the QT interval trait and only bias association findings to the null.

Given the well-supported relationship of QT interval prolongation with sudden cardiac death in the general population, the high rates of SCD in African American populations and the substantial heritability of QT interval duration in the Jackson Heart Study, efforts to define the genetic basis of QT interval variation in populations of African ancestry are warranted The availability of DNA in the large, community-based Jackson Heart Study sampled without regard to phenotype27 will enable large-scale tests for association, including admixture mapping,39 and linkage to identify the genetic variants that underlie the heritable component of myocardial repolarization in people of African ancestry. Given the recent successes in identifying common variants that influence QT interval duration in European-derived samples,40 it is reasonable to expect that such variants will be operative in African-derived samples as supported by a recent report in 1,497 non-Hispanic blacks.41 Whether such variants contribute to risk for SCD or drug-induced arrhythmias will require further work in this and other cohorts.

Supplementary Material

Acknowledgments

We would like to thank the Jackson Heart Study participants and JHS staff for their important contributions to the study of determinants of health in African Americans.

Funding Sources: The Jackson Heart Study is supported by National Institutes of Health by contracts N01-HC-95170, N01-HC-95171, and N01-HC-95172 from the National Heart, Lung, and Blood

Institute and the National Center for Minority Health and Health Disparities. Dr. Newton-Cheh is supported by an NHLBI K23 award (HL080025), a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists.

Abbreviations list

CHD
coronary heart disease
ECG
electrocardiogram
JHS
Jackson Heart Study

Footnotes

Disclosures: Dr. Newton-Cheh is supported to study the genetic basis of QT interval duration by grants from the NIH, Doris Duke Charitable Foundation and the Burroughs Wellcome Fund. No other potential conflicts of interest were reported.

References

1. Heart Disease and Stroke Statistics--2005 Update. American Heart Association; Dallas, TX: 2005.
2. Traven ND, Kuller LH, Ives DG, Rutan GH, Perper JA. Coronary heart disease mortality and sudden death among the 35–44-year age group in Allegheny County, Pennsylvania. Ann.Epidemiol. 1996;6(2):130–136. [PubMed]
3. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104(18):2158–2163. [PubMed]
4. Armstrong D, Wing S, Tyroler HA. Race differences in estimates of sudden coronary heart disease mortality, 1980–1988: the impact of ill-defined death. J.Clin.Epidemiol. 1996;49(11):1247–1251. [PubMed]
5. Gillum RF. Sudden cardiac death in Hispanic Americans and African Americans. Am.J.Public Health. 1997;87(9):1461–1466. [PubMed]
6. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999;99(15):1978–1983. [PubMed]
7. Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, Stampfer MJ, Manson JE. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107(16):2096–2101. [PubMed]
8. Schatzkin A, Cupples LA, Heeren T, Morelock S, Mucatel M, Kannel WB. The epidemiology of sudden unexpected death: risk factors for men and women in the Framingham Heart Study. Am.Heart J. 1984;107(6):1300–1306. [PubMed]
9. Noseworthy PA, Newton-Cheh C. Genetic determinants of sudden cardiac death. Circulation. 2008 [PubMed]
10. Clark LT. Anatomic substrate differences between black and white victims of sudden cardiac death: hypertension, coronary artery disease, or both? Clin.Cardiol. 1989;12(12 Suppl 4):IV13–IV17. [PubMed]
11. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, Arbogast P, Raghunathan TE, Cobb LA. Family history as a risk factor for primary cardiac arrest. Circulation. 1998;97(2):155–160. [PubMed]
12. Dekker LR, Bezzina CR, Henriques JP, Tanck MW, Koch KT, Alings MW, Arnold AE, de Boer MJ, Gorgels AP, Michels HR, Verkerk A, Verheugt FW, Zijlstra F, Wilde AA. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation. 2006;114(11):1140–1145. [PubMed]
13. Kaikkonen KS, Kortelainen ML, Linna E, Huikuri HV. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation. 2006;114(14):1462–1467. [PubMed]
14. Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, Keating MT. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 2002;297(5585):1333–1336. [PubMed]
15. Burke A, Creighton W, Mont E, Li L, Hogan S, Kutys R, Fowler D, Virmani R. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation. 2005;112(6):798–802. [PubMed]
16. Sotoodehnia N, Siscovick DS, Vatta M, Psaty BM, Tracy RP, Towbin JA, Lemaitre RN, Rea TD, Durda JP, Chang JM, Lumley TS, Kuller LH, Burke GL, Heckbert SR. Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation. 2006;113(15):1842–1848. [PubMed]
17. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am.Coll.Cardiol. 2006;47(2):362–367. [PubMed]
18. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. Journal of the American College of Cardiology. 2004;43(4):565–571. [PubMed]
19. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br.Heart J. 1993;70(1):43–48. [PMC free article] [PubMed]
20. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. American Heart Journal. 1957;54:59–68. [PubMed]
21. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell'eta' pediatrica. Clin Pediatr. 1963;45:656–683. [PubMed]
22. Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, Bjerregaard P. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000;94(2):99–102. [PubMed]
23. Roden DM. Drug-induced prolongation of the QT interval. N.Engl.J.Med. 2004;350(10):1013–1022. [PubMed]
24. Newton-Cheh C, Larson MG, Corey DC, Benjamin EJ, Herbert AG, Levy D, D'Agostino RB, O'Donnell CJ. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm. 2005;2(3):277–284. [PubMed]
25. Carpenter MA, Crow R, Steffes M, Rock W, Heilbraun J, Evans G, Skelton T, Jensen R, Sarpong D. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am.J.Med.Sci. 2004;328(3):131–144. [PubMed]
26. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives The ARIC investigators. Am J Epidemiol. 1989;129(4):687–702. [PubMed]
27. Wilson JG, Rotimi CN, Ekunwe L, Royal CD, Crump ME, Wyatt SB, Steffes MW, Adeyemo A, Zhou J, Taylor HA, Jr., Jaquish C. Study design for genetic analysis in the Jackson Heart Study. Ethn.Dis. 2005;15(4 Suppl 6):S6–37. [PubMed]
28. Dubbert PM, Carithers T, Ainsworth BE, Taylor HA, Jr., Wilson G, Wyatt SB. Physical activity assessment methods in the Jackson Heart Study. Ethn Dis. 2005;15(4 Suppl 6):S6, 56–61. [PubMed]
29. van Bemmel JH, Kors JA, van HG. Methodology of the modular ECG analysis system MEANS. Methods Inf.Med. 1990;29(4):346–353. [PubMed]
30. Willems JL, Arnaud P, van Bemmel JH, Bourdillon PJ, Degani R, Denis B, Graham I, Harms FM, Macfarlane PW, Mazzocca G. A reference data base for multilead electrocardiographic computer measurement programs. J Am Coll Cardiol. 1987;10(6):1313–1321. [PubMed]
31. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353–370.
32. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am.J.Hum.Genet. 1998;62(5):1198–1211. [PubMed]
33. Singh BN, Hollenberg NK, Poole-Wilson PA, Robertson JI. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. Journal of Hypertension. 1992;10(4):301–316. [PubMed]
34. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation. 1994;90(2):779–785. [PubMed]
35. Crow RS, Hannan PJ, Folsom AR. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up. Circulation. 2003;108(16):1985–1989. [PubMed]
36. Chapman N, Mayet J, Ozkor M, Lampe FC, Thom SA, Poulter NR. QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population. Am.J.Hypertens. 2001;14(5 Pt 1):455–462. [PubMed]
37. Salles G, Leocadio S, Bloch K, Nogueira AR, Muxfeldt E. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension. 2005;46(5):1207–1212. [PubMed]
38. Hong Y, Rautaharju PM, Hopkins PN, Arnett DK, Djousse L, Pankow JS, Sholinsky P, Rao DC, Province MA. Familial aggregation of QT-interval variability in a general population: results from the NHLBI Family Heart Study. Clin.Genet. 2001;59(3):171–177. [PubMed]
39. Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De TG, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De L, De V, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O'Brien SJ, Reich D. A high-density admixture map for disease gene discovery in african americans. Am.J Hum.Genet. 2004;74(5):1001–1013. [PubMed]
40. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, Bis JC, Marciante K, Rivadeneira F, Noseworthy PA, Sotoodehnia N, Smith NL, Rotter JI, Kors JA, Witteman JC, Hofman A, Heckbert SR, O'Donnell CJ, Uitterlinden AG, Psaty BM, Lumley T, Larson MG, Ch Stricker BH. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet. 2009;41(4):399–406. [PMC free article] [PubMed]
41. Arking DE, Khera A, Xing C, Kao WH, Post W, Boerwinkle E, Chakravarti A. Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population. PLoS ONE. 2009;4(1):e4333. [PMC free article] [PubMed]